연구성과로 돌아가기
2020 연구성과별 연구자 정보 (911 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Selleslag, Dominik | Selleslag, D | 3 | AZ Sint Jan Brugge Oostende AV, Brugge, Belgium | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Montesinos, Pau | Montesinos, P | 4 | Hosp Univ & Politecn La Fe, Valencia, Spain | GYU-2673-2022 | Montesinos, Pau | 0000-0002-3275-5593 | Montesinos, Pau | ||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Montesinos, Pau | Montesinos, P | 4 | Inst Salud Carlos III, CIBERONC, Madrid, Spain | GYU-2673-2022 | Montesinos, Pau | 0000-0002-3275-5593 | Montesinos, Pau | ||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Sayar, Hamid | Sayar, H | 5 | Indiana Univ, Ctr Canc, Indianapolis, IN USA | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Musso, Maurizio | Musso, M | 6 | La Maddalena Casa Cura, Palermo, Italy | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Figuera Alvarez, Angela | Alvarez, AF | 7 | Hosp Univ La Princesa, Madrid, Spain | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Safah, Hana | Safah, H | 8 | Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Tse, William | Tse, W | 9 | Univ Louisville, Sch Med, Louisville, KY 40292 USA | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Sohn, Sang Kyun | Sohn, SK | 10 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Hiwase, Devendra | Hiwase, D | 11 | Royal Adelaide Hosp, Adelaide, SA, Australia | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Chevassut, Timothy | Chevassut, T | 12 | Brighton & Sussex Med Sch, Brighton, E Sussex, England | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Pierdomenico, Francesca | Pierdomenico, F | 13 | Portuguese Inst Oncol Lisbon, Lisbon, Portugal | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | La Torre, Ignazia | La Torre, I | 14 | Celgene, Boudry, Switzerland | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Skikne, Barry | Skikne, B | 15 | Bristol Myers Squibb Co, Princeton, NJ USA | ||||||
| Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial | Skikne, Barry | Skikne, B | 15 | Univ Kansas, Med Ctr, Kansas City, KS 66103 USA |
페이지 이동: